The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2008
Filed:
Jan. 27, 2005
Dvir Dahary, Tel-Aviv, IL;
Sarah Pollock, Tel-Aviv, IL;
Zurit Levine, Herzlia, IL;
Rotem Sorek, Rechovot, IL;
Michal Ayalon-soffer, Ramat-HaSharon, IL;
Pinchas Akiva, Ramat-Gan, IL;
Amir Toporik, Azur, IL;
Osnat Sella-tavor, Kfar Kish, IL;
Shirley Sameah-greenwald, Kfar-Saba, IL;
Dvir Dahary, Tel-Aviv, IL;
Sarah Pollock, Tel-Aviv, IL;
Zurit Levine, Herzlia, IL;
Rotem Sorek, Rechovot, IL;
Michal Ayalon-Soffer, Ramat-HaSharon, IL;
Pinchas Akiva, Ramat-Gan, IL;
Amir Toporik, Azur, IL;
Osnat Sella-Tavor, Kfar Kish, IL;
Shirley Sameah-Greenwald, Kfar-Saba, IL;
Compugen Ltd., Tel Aviv, IL;
Abstract
Novel markers for prostate cancer that are both sensitive and accurate. Furthermore, these markers are able to distinguish between prostate cancer and benign prostate hyperplasia ('BPH'). These markers are overexpressed in prostate cancer specifically, as opposed to normal prostate tissue and/or BPH. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of prostate cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between prostate cancer and non-cancerous states.